Piper Sandler raised the firm’s price target on Hercules Capital to $21 from $20 and keeps an Overweight rating on the shares. The firm continues to be positive on Hercules and believes the company will be a beneficiary in the shifting competitive environment in venture lending driven by bank turmoil in early 2023. A large competitor’s void from the venture lending space should allow Hercules Capital to add new clients and deepen relationships with current clients.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTGC:
- Hercules Capital price target raised to $19 from $18 at JMP Securities
- Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
- Largest borrow rate increases among liquid names
- Hercules Capital price target raised to $19 from $18.50 at Ladenburg
- Hercules Capital Announces Generous Quarterly Cash Distribution